Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-02-02 @ 1:22 AM
Study NCT ID:
NCT04300803
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2020-08-28
First Post:
2020-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL
Sponsor:
MorphoSys AG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MOR208N001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |